Nathan Singh

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Acute Myeloid Leukemia

Transcription Factor

Regulatory T Cells

Top Venues

Cancer immunology research

Cancer discovery

Nature medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ju-Fang Chang, Jack H Landmann, Tien-Ching Chang, Mehmet Emrah Selli, Yangdon Tenzin, John M Warrington, Julie Ritchey, Yu-Sung Hsu, Michael Joseph Slade, Deepesh Kumar Gupta, John F Dipersio, Alex S Holehouse, Nathan Singh
Rational protein engineering to enhance MHC-independent T cell receptors. Cancer discovery (2024)
Julie K Jadlowsky, Ju-Fang Chang, David H Spencer, John M Warrington, Bruce L Levine, Carl H June, Joseph A Fraietta, Nathan Singh
Regulatory Considerations for Genome-Edited T-cell Therapies. Cancer immunology research (2024)
Ju-Fang Chang, Nils Wellhausen, Nils Wolfgang Engel, Jack H Landmann, Caitlin R Hopkins, January Salas-McKee, Adham S Bear, Mehmet Emrah Selli, Sangya Agarwal, Julie K Jadlowsky, Gerald P Linette, Saar I Gill, Carl H June, Joseph A Fraietta, Nathan Singh
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors. Cancer immunology research 12 (9) (2024)
Ju-Fang Chang, Nils Wellhausen, Nils Wolfgang Engel, Jack H Landmann, Caitlin R Hopkins, January Salas-McKee, Adham S Bear, Mehmet Emrah Selli, Sangya Agarwal, Julie K Jadlowsky, Gerald P Linette, Saar I Gill, Carl H June, Joseph A Fraietta, Nathan Singh
Identification of core techniques that enhance genome editing of human T cells expressing synthetic antigen receptors. Cancer immunology research (2024)
Ju-Fang Chang, Jack H Landmann, Tien-Ching Chang, Mehmet Emrah Selli, Yangdon Tenzin, John M Warrington, Julie Ritchey, Yu-Sung Hsu, Michael Joseph Slade, Deepesh Kumar Gupta, John F Dipersio, Alex S Holehouse, Nathan Singh
Rational protein engineering to enhance MHC-independent T cell receptors. Cancer discovery (2024)
Julie K Jadlowsky, Ju-Fang Chang, David H Spencer, John M Warrington, Bruce L Levine, Carl H June, Joseph A Fraietta, Nathan Singh
Regulatory Considerations for Genome-Edited T-cell Therapies. Cancer immunology research 12 (9) (2024)
Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G Karrison, Rachel Treitman, Manali Kamdar, Bradley M Haverkos, James Godfrey, Melissa A Babcook, Timothy J Voorhees, Sophie Gabrielle Carlson, Daria Gaut, Caspian Oliai, Jason T Romancik, Allison M Winter, Brian T Hill, Radhika Bansal, Jose C Villasboas Bisneto, Imran A Nizamuddin, Reem Karmali, Lindsey A Fitzgerald, Deborah M Stephens, Priyanka A Pophali, Asaad Trabolsi, Jonathan H Schatz, Marie Hu, Veronika Bachanova, Michael Joseph Slade, Nathan Singh, Nausheen Ahmed, Joseph P McGuirk, Michael R Bishop, Peter A Riedell, Justin Kline
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: Outcomes from 15 U.S. institutions. Blood advances (2023)
Amanda Heard, Jack H Landmann, Ava R Hansen, Alkmini Papadopolou, Yu-Sung Hsu, Mehmet Emrah Selli, John M Warrington, John Lattin, Jufang Chang, Helen Ha, Martina Haug-Kroeper, Balraj Doray, Saar Gill, Marco Ruella, Katharina E Hayer, Matthew D Weitzman, Abby M Green, Regina Fluhrer, Nathan Singh
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19. Nature communications 13 (1) (2022)
Nathan Singh, Noelle V Frey, Boris Engels, David M Barrett, Olga Shestova, Pranali Ravikumar, Katherine D Cummins, Yong Gu Lee, Raymone Pajarillo, Inkook Chun, Amy Shyu, Steven L Highfill, Andrew Price, Linlin Zhao, Liaomin Peng, Brian Granda, Melissa Ramones, Xueqing Maggie Lu, David A Christian, Jessica Perazzelli, Simon F Lacey, Nathan H Roy, Janis K Burkhardt, Florent Colomb, Mohammad Damra, Mohamed Abdel-Mohsen, Ting Liu, Dongfang Liu, Daron M Standley, Regina M Young, Jennifer L Brogdon, Stephan A Grupp, Carl H June, Shannon L Maude, Saar Gill, Marco Ruella
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells. Nature medicine 27 (5) (2021)